Joint Formulary & PAD

Estradiol with medroxyprogesterone - Menopausal disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Tridestra tablets - consider changing to a newer, 1st or 2nd line option.
 

Status 2

Non Formulary
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Indivina tablets - consider changing to a newer, 1st or 2nd line option.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Estradiol with medroxyprogesterone
Indication :
Menopausal disorders
Group Name :
Keywords :
hormone replacement therapy, HRT, menopause, sequential combined therapy, continuous combined therapy, menopausal symptoms
Brand Names Include :
Tridestra, Indivina
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Estradiol with medroxyprogesterone is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations:

Menopause | Health topics A to Z | CKS | NICE